Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. / Togsverd-Bo, Katrine; Lerche, Catharina M; Philipsen, Peter A; Poulsen, Thomas; Wulf, Hans Christian; Haedersdal, Merete.

I: Experimental Dermatology Online, Bind 21, Nr. 4, 2012, s. 260-264.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Togsverd-Bo, K, Lerche, CM, Philipsen, PA, Poulsen, T, Wulf, HC & Haedersdal, M 2012, 'Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation', Experimental Dermatology Online, bind 21, nr. 4, s. 260-264. https://doi.org/10.1111/j.1600-0625.2012.01442.x

APA

Togsverd-Bo, K., Lerche, C. M., Philipsen, P. A., Poulsen, T., Wulf, H. C., & Haedersdal, M. (2012). Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. Experimental Dermatology Online, 21(4), 260-264. https://doi.org/10.1111/j.1600-0625.2012.01442.x

Vancouver

Togsverd-Bo K, Lerche CM, Philipsen PA, Poulsen T, Wulf HC, Haedersdal M. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. Experimental Dermatology Online. 2012;21(4):260-264. https://doi.org/10.1111/j.1600-0625.2012.01442.x

Author

Togsverd-Bo, Katrine ; Lerche, Catharina M ; Philipsen, Peter A ; Poulsen, Thomas ; Wulf, Hans Christian ; Haedersdal, Merete. / Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. I: Experimental Dermatology Online. 2012 ; Bind 21, Nr. 4. s. 260-264.

Bibtex

@article{69947f03c6b74be69cfaecd9aa17dcb1,
title = "Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation",
abstract = "Topical photodynamic therapy (PDT) with methyl-aminolevulinate (MAL) is a well-established treatment for precancerous skin lesions and non-melanoma skin cancer. Treatment outcomes are less effective for thick than for superficial lesions, which are presumed to be due to insufficient PpIX biodistribution in tumour tissue. Hexyl-aminolevulinate (HAL) is a more lipophilic photosensitizer precursor than MAL and may penetrate the skin to a greater depth and more homogeneously. We compared HAL- and MAL-induced PpIX accumulation in specific skin compartments using concentrations of 2%, 6% and 20% HAL and MAL on long-term UV-irradiated mouse skin. Furthermore, 20% HAL and 20% MAL were applied to non-irradiated skin. Porphyrin fluorescence was measured by fluorescence microscopy in selected skin regions: the epidermis, superficial dermis, deep dermis and sebaceous gland epithelium down to a depth of 1 mm. We found higher PpIX fluorescence intensities in epidermis and sebaceous gland epithelium from 2%, 6% and 20% HAL (median 72-104 au) than in corresponding concentrations of MAL (median 35-69 au) (P <0.01). Fluorescence intensities in the superficial (35 au) and deep dermis (32 au) were similar for HAL and MAL (P = 0.51) and lower than epidermal fluorescence intensities (P <0.001). Significantly, higher median PpIX fluorescence intensities (64 au) were found in 20% MAL-incubated skin irradiated with UV than in non-irradiated skin (48 au) (P <0.001). HAL-induced fluorescence intensities did not depend on UV exposure (HAL 20%, UV: 72 au, non-UV: 70 au) (P = 0.87). In conclusion, HAL express high affinity for epidermis and sebaceous gland epithelium, and MAL for actinically damaged skin, which raises future perspectives for improved selectivity in PDT.",
author = "Katrine Togsverd-Bo and Lerche, {Catharina M} and Philipsen, {Peter A} and Thomas Poulsen and Wulf, {Hans Christian} and Merete Haedersdal",
note = "{\textcopyright} 2012 John Wiley & Sons A/S.",
year = "2012",
doi = "10.1111/j.1600-0625.2012.01442.x",
language = "English",
volume = "21",
pages = "260--264",
journal = "Experimental Dermatology",
issn = "1600-0625",
publisher = "Wiley",
number = "4",

}

RIS

TY - JOUR

T1 - Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation

AU - Togsverd-Bo, Katrine

AU - Lerche, Catharina M

AU - Philipsen, Peter A

AU - Poulsen, Thomas

AU - Wulf, Hans Christian

AU - Haedersdal, Merete

N1 - © 2012 John Wiley & Sons A/S.

PY - 2012

Y1 - 2012

N2 - Topical photodynamic therapy (PDT) with methyl-aminolevulinate (MAL) is a well-established treatment for precancerous skin lesions and non-melanoma skin cancer. Treatment outcomes are less effective for thick than for superficial lesions, which are presumed to be due to insufficient PpIX biodistribution in tumour tissue. Hexyl-aminolevulinate (HAL) is a more lipophilic photosensitizer precursor than MAL and may penetrate the skin to a greater depth and more homogeneously. We compared HAL- and MAL-induced PpIX accumulation in specific skin compartments using concentrations of 2%, 6% and 20% HAL and MAL on long-term UV-irradiated mouse skin. Furthermore, 20% HAL and 20% MAL were applied to non-irradiated skin. Porphyrin fluorescence was measured by fluorescence microscopy in selected skin regions: the epidermis, superficial dermis, deep dermis and sebaceous gland epithelium down to a depth of 1 mm. We found higher PpIX fluorescence intensities in epidermis and sebaceous gland epithelium from 2%, 6% and 20% HAL (median 72-104 au) than in corresponding concentrations of MAL (median 35-69 au) (P <0.01). Fluorescence intensities in the superficial (35 au) and deep dermis (32 au) were similar for HAL and MAL (P = 0.51) and lower than epidermal fluorescence intensities (P <0.001). Significantly, higher median PpIX fluorescence intensities (64 au) were found in 20% MAL-incubated skin irradiated with UV than in non-irradiated skin (48 au) (P <0.001). HAL-induced fluorescence intensities did not depend on UV exposure (HAL 20%, UV: 72 au, non-UV: 70 au) (P = 0.87). In conclusion, HAL express high affinity for epidermis and sebaceous gland epithelium, and MAL for actinically damaged skin, which raises future perspectives for improved selectivity in PDT.

AB - Topical photodynamic therapy (PDT) with methyl-aminolevulinate (MAL) is a well-established treatment for precancerous skin lesions and non-melanoma skin cancer. Treatment outcomes are less effective for thick than for superficial lesions, which are presumed to be due to insufficient PpIX biodistribution in tumour tissue. Hexyl-aminolevulinate (HAL) is a more lipophilic photosensitizer precursor than MAL and may penetrate the skin to a greater depth and more homogeneously. We compared HAL- and MAL-induced PpIX accumulation in specific skin compartments using concentrations of 2%, 6% and 20% HAL and MAL on long-term UV-irradiated mouse skin. Furthermore, 20% HAL and 20% MAL were applied to non-irradiated skin. Porphyrin fluorescence was measured by fluorescence microscopy in selected skin regions: the epidermis, superficial dermis, deep dermis and sebaceous gland epithelium down to a depth of 1 mm. We found higher PpIX fluorescence intensities in epidermis and sebaceous gland epithelium from 2%, 6% and 20% HAL (median 72-104 au) than in corresponding concentrations of MAL (median 35-69 au) (P <0.01). Fluorescence intensities in the superficial (35 au) and deep dermis (32 au) were similar for HAL and MAL (P = 0.51) and lower than epidermal fluorescence intensities (P <0.001). Significantly, higher median PpIX fluorescence intensities (64 au) were found in 20% MAL-incubated skin irradiated with UV than in non-irradiated skin (48 au) (P <0.001). HAL-induced fluorescence intensities did not depend on UV exposure (HAL 20%, UV: 72 au, non-UV: 70 au) (P = 0.87). In conclusion, HAL express high affinity for epidermis and sebaceous gland epithelium, and MAL for actinically damaged skin, which raises future perspectives for improved selectivity in PDT.

U2 - 10.1111/j.1600-0625.2012.01442.x

DO - 10.1111/j.1600-0625.2012.01442.x

M3 - Journal article

C2 - 22320713

VL - 21

SP - 260

EP - 264

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 1600-0625

IS - 4

ER -

ID: 48466202